These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37206871)

  • 21. Sex/gender differences in spontaneous reports to a French Addictovigilance centre.
    Peyriére H; Dampierre A; Vallo R; Lestienne M; Eiden C; Donnadieu H
    Arch Womens Ment Health; 2024 Jul; ():. PubMed ID: 38980402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rise in cases of nitrous oxide abuse: neurological complications and biological findings.
    Einsiedler M; Voulleminot P; Demuth S; Kalaaji P; Bogdan T; Gauer L; Reschwein C; Nadaj-Pakleza A; de Sèze J; Kremer L; Schroder I; Bigaut K
    J Neurol; 2022 Feb; 269(2):577-582. PubMed ID: 34245346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of new psychoactive substances to mimic prescription drugs: The trend in France.
    Batisse A; Eiden C; Peyriere H; Djezzar S;
    Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change.
    Aquizerate A; Laforgue EJ; Istvan M; Rousselet M; Gerardin M; Jouanjus E; Libert F; ; Guerlais M; Victorri-Vigneau C
    Eur J Public Health; 2023 Apr; 33(2):169-175. PubMed ID: 36749030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
    Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
    Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
    [No Abstract]   [Full Text] [Related]  

  • 26. Nitrous oxide-induced myeloneuropathy: an emerging public health issue.
    McCormick JP; Sharpe S; Crowley K; Dudley A; O'Laoi R; Barry M; Owens L; Doherty CP; Redmond J; Yeung SJ
    Ir J Med Sci; 2023 Feb; 192(1):383-388. PubMed ID: 35150382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MEOPA use practices in a university hospital: Which conformity?].
    Victorri-Vigneau C; Paille C; Joyau C; Veyrac G; Cosset C; Le Pelletier A; Jolliet P; Nizard J; Kuhn E
    Therapie; 2017 Dec; 72(6):659-663. PubMed ID: 28647109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Involvement of addictovigilance in emergency department for the detection of abuse and dependence cases: 3 years of experience].
    Serre A; Eiden C; Gourhant V; Laureau M; Perier D; Giraud I; Sebbane M; Peyrière H
    Therapie; 2018 Dec; 73(6):501-509. PubMed ID: 30017376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New patterns of substance use and abuse among French adolescents, a knowledge synthesis].
    Jeanne G; Purper-Ouakil D; Rigole H; Franc N
    Encephale; 2017 Aug; 43(4):346-353. PubMed ID: 27720453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network].
    Frauger E; Pochard L; Boucherie Q; Giocanti A; Chevallier C; Daveluy A; Gibaja V; Caous AS; Eiden C; Authier N; Le Boisselier R; Guerlais M; Jouanjus É; Lepelley M; Pizzoglio V; Pain S; Richard N; Micallef J;
    Therapie; 2017 Sep; 72(4):491-501. PubMed ID: 28343650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use.
    Kaar SJ; Ferris J; Waldron J; Devaney M; Ramsey J; Winstock AR
    J Psychopharmacol; 2016 Apr; 30(4):395-401. PubMed ID: 26912510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of psychostimulants in a sexual context: Analysis of cases reported to the French network of Addictovigilance Centers].
    Batisse A; Peyrière H; Eiden C; Courné MA; Djezzar S;
    Therapie; 2016 Oct; 71(5):447-455. PubMed ID: 27203172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitrous Oxide Inhalant Use Disorder Preceding Symptoms Concerning for Primary Psychotic Illness.
    Roberts D; Farahmand P; Wolkin A
    Am J Addict; 2020 Nov; 29(6):525-527. PubMed ID: 32333625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers for the diagnosis and monitoring of nitrous oxide intoxication: objectives and methodology of the SFBC Working Group.
    Denimal D; Badiou S; Blin J; Bonnan M; Boullier A; Chauvin A; Dupont A; Diesnis R; Dupré T; Fabresse N; Gernez É; Imbard A; Kim I; Mondesert É; Niguet JP; Parant F; Redonnet-Vernhet I; Trillot N; Grzych G
    Ann Biol Clin (Paris); 2024 Feb; 81(6):585-590. PubMed ID: 38391163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitrous oxide-induced neurological disorders: an increasing public health concern.
    Redmond J; Cruse B; Kiers L
    Intern Med J; 2022 May; 52(5):740-744. PubMed ID: 34569693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does nitrous oxide addiction exist? An evaluation of the evidence for the presence and prevalence of substance use disorder symptoms in recreational nitrous oxide users.
    Back S; Kroon E; Colyer-Patel K; Cousijn J
    Addiction; 2024 Apr; 119(4):609-618. PubMed ID: 37904333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network.
    Gandolfo P; Soeiro T; Jouve É; Revol B; Daveluy A; Bertin C; Eiden C; Gibaja V; Chaouachi L; Pérault-Pochat MC; Chevallier C; Aquizérate A; Le Boisselier R; Carton L; Lapeyre-Mestre M; Frauger É; Lacroix C; Micallef J
    Fundam Clin Pharmacol; 2024 Oct; 38(5):978-987. PubMed ID: 38372190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case Study: Naltrexone for the Treatment of Nitrous Oxide Use.
    Ickowicz S; Brar R; Nolan S
    J Addict Med; 2020; 14(5):e277-e279. PubMed ID: 32142053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloneuropathy from whipped cream bulbs presenting as conversion disorder.
    Brett A
    Aust N Z J Psychiatry; 1997 Feb; 31(1):131-2. PubMed ID: 9088497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends and associated risks in adolescent substance use: E-cigarette use and nitrous oxide use.
    Huizink AC
    Curr Opin Psychol; 2022 Jun; 45():101312. PubMed ID: 35313182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.